Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Learn timing strategies for harvesting gains in retirement index funds, including tax-aware harvest windows and portfolio rebalancing tips.
21,708 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
FedEx reports earnings Tuesday, and traders want a clear take on demand, costs, and guidance. This guide breaks down ...
AI headlines sent IT-services stocks lower, but is the pullback justified? This guide explains what drives the move, ...
Lawmakers and insurers are weighing a faster disaster payout model that would centralize leadership and pool risk to ...
Netflix trades below $78 as investors weigh ad-supported growth and margin targets. Analysts dispute whether the stoc...
Analysts issue refreshed Tuesday notes on a slate of large-cap names, signaling where investors may push for upside a...
Could Monero surpass Cardano by 2028? This article lays out the pathways, risks, and strategies for investors trackin...
JB Straubel’s initial pitch to Elon Musk missed the mark on aviation, but his pivot to electric cars launched Tesla t...
Tesla breaches a key price level near $382 as investors weigh margin pressures from tech compression and intensifying...
A major insider sale at TransMedics grabbed attention after the stock slumped about 45%. This article dives into what...
Carnival beat on the bottom line and top line, but the stock sank on the day. Analysts point to a price prediction: c...
Investors are eyeing a potential rebound for Figma as enterprise adoption grows and AI-driven updates sharpen the pla...